SCHEMBL6425935

SCHEMBL6425935

CCCCOC(C)CCCC(=O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 1/20 0.48
GPR84 Q9NQS5 7/20 0.47
PPARG P37231 7/20 0.47
PPARD Q03181 7/20 0.47
PPARA Q07869 7/20 0.47
HDAC11 Q96DB2 5/20 0.47
TSHR P16473 4/20 0.47
PTPN1 P18031 3/20 0.47
ALDH1A1 P00352 3/20 0.47
TLR2 O60603 2/20 0.47
TDP1 Q9NUW8 2/20 0.47
FABP4 P15090 2/20 0.47
FFAR1 O14842 2/20 0.47
FFAR4 Q5NUL3 2/20 0.47
KMT2A Q03164 2/20 0.47
SLC22A6 Q4U2R8 1/20 0.47
SLC22A8 Q8TCC7 1/20 0.47
MEN1 O00255 1/20 0.47
ESR1 P03372 1/20 0.47
ALOX15 P16050 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6429527 0.95 FFAR4 (0.53) AKR1B1GPR84PPARGPPARDPPARA
SCHEMBL6425358 0.91 AKR1B1 (0.45) AKR1B1GPR84PPARGPPARDPPARA
SCHEMBL7171241 0.91 AKR1B1 (0.45) AKR1B1GPR84PPARGPPARDPPARA
SCHEMBL9489370 0.89 FFAR4 (0.56) AKR1B1GPR84PPARGPPARDPPARA
SCHEMBL14534571 0.87 AKR1B1 (0.45) AKR1B1GPR84PPARGPPARDPPARA
SCHEMBL9487311 0.85 AKR1B1 (0.48) AKR1B1GPR84PPARGPPARDPPARA
SCHEMBL6381219 0.85 FFAR4 (0.50) AKR1B1GPR84PPARGPPARDPPARA
SCHEMBL10781727 0.84 DGKA (0.50) AKR1B1GPR84PPARGPPARDPPARA
SCHEMBL21990987 0.84 AKR1B1 (0.40) AKR1B1GPR84PPARGPPARDPPARA
SCHEMBL9455621 0.84 FFAR4 (0.53) AKR1B1GPR84PPARGPPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1878546-A Combination comprising an alpha-2 delta ligand and an SSRI and/or SNRI for the treatment of depression and anxiety WARNER LAMBERT CO (US) 2006-12-13 CN disclosed
CN-1678298-A Use of an alpha2delta ligand such as gabapentin or pregabalin for treating ttention deficit hyperactivity disorder WARNER LAMBERT CO (US) 2005-10-05 CN disclosed
US-20050042536-A1 Photosensitive resin composition comprising quinonediazide sulfate ester compound DONGJIN SEMICHEM CO. LTD. (KR) 2005-02-24 US disclosed
WO-2003036388-A1 PHOTOSNESITIVE RESIN COMPOSITION COMPRISING QUINONEDIAZIDE SULFATE ESTER COMPOUND DONGJIN SEMICHEM CO., LTD. (KR) 2003-05-01 WO disclosed